PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kim SJ et al. Effects of methyl gallate on arachidonic acid metabolizing enzymes: Cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2006 Arch. Pharm. Res. pmid:17121182
Berruyer C et al. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. 2006 J. Exp. Med. pmid:17145956
Qu WM et al. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:17093043
Arai I [Role of cutaneous prostaglandin D2 production on scratching dermatitis in mice]. 2006 Nippon Yakurigaku Zasshi pmid:17167214
Akabane H et al. Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells. 2006 Allergol Int pmid:17130681
Ishimura M et al. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. 2006 Allergol Int pmid:17130683
Pérez S et al. The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. 2006 Biochim. Biophys. Acta pmid:16545597
Wise H Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells. 2006 Eur. J. Pharmacol. pmid:16545798
Wang XS et al. Functional characterization of human mast cells cultured from adult peripheral blood. 2006 Int. Immunopharmacol. pmid:16546715
Sawai H et al. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system. 2006 Mol. Cancer Res. pmid:16547153
Fu YG et al. Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1. 2006 Cancer Lett. pmid:16412567
Wung BS et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells. 2006 Life Sci. pmid:16413037
Mathiesen JM et al. On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2. 2006 Mol. Pharmacol. pmid:16418339
Barreto EO et al. High levels of filamentous actin and apoptosis correlate with mast cell refractoriness under alloxan-evoked diabetes. 2006 Life Sci. pmid:16647092
Funovics P et al. Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells. 2006 Prostaglandins Other Lipid Mediat. pmid:16647637
Jin MH et al. Anti-inflammatory activity of Ailanthus altissima in ovalbumin-induced lung inflammation. 2006 Biol. Pharm. Bull. pmid:16651713
Mohri I et al. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. 2006 J. Neurosci. pmid:16624958
Hauser B et al. Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. 2006 Intensive Care Med pmid:16534570
Lee SJ et al. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation. 2006 Mol. Pharmacol. pmid:16611854
Rockwell CE et al. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. 2006 Mol. Pharmacol. pmid:16611855
Arnold R and König W Peroxisome proliferator-activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells. 2006 Virology pmid:16616290
Merwald H et al. Induction of the 72-kilodalton heat shock protein and protection from ultraviolet B-induced cell death in human keratinocytes by repetitive exposure to heat shock or 15-deoxy-delta(12,14)-prostaglandin J2. 2006 Cell Stress Chaperones pmid:16572732
Sato TA and Mitchell MD Preferential production of prostaglandin D2 by lipopolysaccharide stimulated human choriodecidual explants. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:16380246
Cheng K et al. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16617107
Arnold R and König W Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells. 2006 Virology pmid:16330064
Sheddan NA and Mulzer J Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues. 2006 Org. Lett. pmid:16805562
Kohno S et al. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma. 2006 Biomed. Pharmacother. pmid:16337105
Chiang PC et al. Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells. 2006 Eur. J. Pharmacol. pmid:16806159
Xie Y et al. Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. 2006 Diabetes Obes Metab pmid:16367886
Ogburn KD et al. Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells. 2006 Neurobiol. Dis. pmid:16406650
Honma Y et al. Effects of indomethacin and dexamethasone on mechanical scratching-induced cutaneous barrier disruption in mice. 2006 Exp. Dermatol. pmid:16761958
El Mezayen R et al. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation. 2006 Immunol. Lett. pmid:16762422
Lin TN et al. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16385084
Ding J et al. Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors. 2006 Mol. Carcinog. pmid:16385588
Landar A et al. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16387790
Brazís P et al. Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporin A on cutaneous histamine and prostaglandin D2 release. 2006 Vet. Dermatol. pmid:16674731
Hickson-Bick DL et al. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. 2006 Shock pmid:16680021
Son MJ et al. Naturally occurring biflavonoid, ochnaflavone, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2006 Arch. Pharm. Res. pmid:16681032
Wang WM et al. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts]. 2006 Zhonghua Yi Xue Za Zhi pmid:16681946
Sun K et al. PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression. 2006 Acta Pharmacol. Sin. pmid:16723090
Ou Z et al. Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat. 2006 Brain Res. pmid:16725118
Lee S et al. Rosiglitazone ameliorates cisplatin-induced renal injury in mice. 2006 Nephrol. Dial. Transplant. pmid:16728429
Rajasingh J and Bright JJ 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. 2006 Exp. Cell Res. pmid:16737695
Wang Z et al. Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells. 2006 J. Biol. Chem. pmid:16737963
Yasugi E et al. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. 2006 Dev. Growth Differ. pmid:16573735
Cuzzocrea S Peroxisome proliferator-activated receptors and acute lung injury. 2006 Curr Opin Pharmacol pmid:16580256
Brannan JD et al. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. 2006 Eur. Respir. J. pmid:16707393
Suzuki T et al. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. 2006 Endocr. Relat. Cancer pmid:16601291
Bate C et al. Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells. 2006 Neuropharmacology pmid:16289250
Bellows CF et al. Modulation of macrophage nitric oxide production by prostaglandin D2. 2006 J. Surg. Res. pmid:16289592
Helliwell RJ et al. Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. 2006 J. Clin. Endocrinol. Metab. pmid:16291703
Stamatakis K et al. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. 2006 J. Am. Soc. Nephrol. pmid:16291835
Landar A et al. Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria. 2006 Biochem. J. pmid:16268779
Cesario RM et al. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. 2006 Cancer Lett. pmid:16271436
Ye P et al. [The role of peroxisome proliferator-activated receptor gamma in proliferation of cardiac non myocytes]. 2006 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21162229
Garg TK and Chang JY Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12, 14-prostaglandin J2. 2006 J. Neuroimmunol. pmid:16225932
Shiraki T et al. Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARgamma ligand-binding domain by multi-wavelength global fitting. 2006 Biochem. J. pmid:16236024
Benkirane K et al. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16155101
Zhang YF et al. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense. 2006 Am. J. Nephrol. pmid:17183189
Fernández PL [Stress and inflammatory bowell disease (I.B.D). Therapeutic strategies]. 2006 An R Acad Nac Med (Madr) pmid:17172222
Cho WH et al. 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. 2006 Neurochem. Res. pmid:17006759
Maciejewski-Lenoir D et al. Langerhans cells release prostaglandin D2 in response to nicotinic acid. 2006 J. Invest. Dermatol. pmid:17008871
Wilson RJ et al. GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist. 2006 Br. J. Pharmacol. pmid:16604093
Millán O et al. Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis. 2006 Carcinogenesis pmid:16113051
Tanaka H et al. Polymer-assisted solution-phase synthesis and neurite-outgrowth-promoting activity of 15-deoxy-delta(12,14)-PGJ2 derivatives. 2006 Chem Asian J pmid:17441107
Gulliksson M et al. Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. 2006 Allergy pmid:17073880
Phulwani NK et al. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. 2006 J. Neurochem. pmid:17074064
Kim EH et al. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. 2006 Ann. N. Y. Acad. Sci. pmid:17384282
Núñez NP et al. PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. 2006 Cancer Lett. pmid:15979236
Aquila S et al. Peroxisome proliferator-activated receptor (PPAR)gamma is expressed by human spermatozoa: its potential role on the sperm physiology. 2006 J. Cell. Physiol. pmid:16972250
Gayarre J et al. Addition of electrophilic lipids to actin alters filament structure. 2006 Biochem. Biophys. Res. Commun. pmid:16979589
Zhang YJ et al. Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2). 2006 Am. J. Nephrol. pmid:16864989
Schratl P et al. Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase. 2006 Eur. J. Immunol. pmid:16906532
Ciucci A et al. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway. 2006 Mol. Pharmacol. pmid:16908599
Egan K and FitzGerald GA Eicosanoids and the vascular endothelium. 2006 Handb Exp Pharmacol pmid:16999220
Sugimoto M et al. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice. 2006 Exp. Dermatol. pmid:17002684
Feldon SE et al. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. 2006 Am. J. Pathol. pmid:17003477
Peeraully MR et al. Prostaglandin D2 and J2-series (PGJ2, Delta12-PGJ2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes. 2006 Pflugers Arch. pmid:16924534
Eucker J et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. 2006 Anticancer Drugs pmid:16926626
Coyle AT and Kinsella BT Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. 2006 Biochem. Pharmacol. pmid:16499875
Makino N et al. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. 2006 Cell Biochem. Biophys. pmid:16456235
Figarella K et al. Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. 2006 Cell Death Differ. pmid:16456581
Belvisi MG et al. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. 2006 Eur. J. Pharmacol. pmid:16458290
Rolin S et al. Prostanoids as pharmacological targets in COPD and asthma. 2006 Eur. J. Pharmacol. pmid:16458293
Masuda H et al. 15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats. 2006 Urology pmid:16461118
Lee E et al. Anti-asthmatic activity of an ethanol extract from Saururus chinensis. 2006 Biol. Pharm. Bull. pmid:16462020
Raetz CR et al. Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. 2006 J. Lipid Res. pmid:16479018
Nakahata Y et al. The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks. 2006 BMC Mol. Biol. pmid:16483373
Damrongsri D et al. Effects of Delta12-prostaglandin J2 on bone regeneration and growth factor expression in rats. 2006 Clin Oral Implants Res pmid:16441784
Mesquita-Santos FP et al. Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. 2006 J. Immunol. pmid:16424158
Martín AR et al. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. 2006 Br. J. Pharmacol. pmid:16474422
Kang HY et al. Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis. 2006 Arch. Dermatol. Res. pmid:16474974
Schröder O et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells. 2006 J. Lipid Res. pmid:16495511
King VL et al. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:16514081
Ray DM et al. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms. 2006 J. Immunol. pmid:17015690
Urade Y and Mohri I [Sleep and brain function]. 2006 No To Hattatsu pmid:16986732
Kim EH and Surh YJ 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. 2006 Biochem. Pharmacol. pmid:16987499
Diaz BL et al. Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner. 2006 Biochim. Biophys. Acta pmid:17064958
Qin S et al. Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. 2006 Invest. Ophthalmol. Vis. Sci. pmid:17065531
Gyles SL et al. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. 2006 Immunology pmid:17067313